Epidemic of chronic diseases focus of Oxford Health Alliance Conference

October 26, 2005

Global leaders and researchers will address the world's leading causes of death in a three-day Oxford Health Alliance conference at the Yale School of Medicine starting October 30 at The Anlyan Center, 300 Cedar St.

The four biggest killers--cardiovascular disease, several cancers, diabetes and chronic respiratory disease--are tied to three main risks -tobacco use, unhealthy diets and a lack of physical activity. Researchers and policy makers will present compelling new evidence on the devastating economic and human impact of these diseases, which have received too little attention from governments and policy makers, in countries as diverse as China and India, South Africa and Brazil and the United States.

The conference is a call to action by researchers and industry leaders to address what the organizers call a preventable tragedy. The Oxford Health Alliance, through its action research arm, enables chronic-disease researchers from both the developed and developing worlds to pilot research projects. Their progress will be reported along with new global actions in an annual review to be released at the meeting. The overall goal of the conference is to raise awareness about the need for timely action on policy and at the grass roots level.

The diverse members of The Oxford Health Alliance are a multi-disciplinary consortium, including representatives from industry, non-governmental organizations, academia and U.N. agencies, who work together on many fronts, including community-based initiatives designed to raise awareness about the need for intervention and advocacy for effective policies.

"The World Health Organization recently released a major report showing that chronic diseases are the dominant cause of death in developing and developed countries," said Derek Yach, professor of global health in the Department of Epidemiology and Public Health (EPH) at Yale and the event's host. "This conference will emphasize the urgent need for effective actions to reduce tobacco use and obesity and promote physical activity."

Major presentations will be given by Dean of Yale School of Medicine Robert J. Alpern, M.D., John Bell, Regius Professor of Medicine at Oxford, Iowa Senator Tom Harkin, Chief Medical Officer of the United Kingdom Department of Health, Sir Liam Donaldson, and Bernard Lown, 1985 Nobel Prize Winner for Peace and Director of Lown Cardiovascular Center and Research Foundation.

Additional presentations by Chris Murray and Alan Lopez will call for better global data to guide actions; Kelly Brownell of the Yale Rudd Center for Food Policy and Obesity will highlight the dangers of obesity becoming "normalized" and Liming Lee, from the Academy of Medical Science/Peking Union Medical College, will provide new evidence that obesity is spreading in China.

The content and focus of 20 new community-based research projects from all continents will be presented. Dick Crawford of McDonald's will present the role of the private food industry in developing solutions to the obesity crisis, while Yale's efforts to transform college food will be outlined by Yale student Sarah Milby of Community Health Educators Nutrition Group.

Lars Rebien Sørensen, CEO of healthcare company Novo Nordisk, and John Seffrin, President of the American Cancer Society, will join John Bell of Oxford for closing remarks.
A complete conference agenda is available at http://www.oxha.org/meetings

For additional information, please contact:

Stig Pramming, executive director, Oxford Health Alliance
+45 3079 6534

Derek Yach, Yale EPH and Board Member, Oxford Health Alliance

Yale University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.